SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-012564
Filing Date
2016-04-27
Accepted
2016-04-26 17:43:45
Documents
5
Period of Report
2016-06-15
Effectiveness Date
2016-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2228387zdef14a.htm DEF 14A 338412
2 G794120.JPG g794120.jpg GRAPHIC 10698
3 G87962BI01I001.JPG g87962bi01i001.jpg GRAPHIC 133070
4 G87962BI01I002.JPG g87962bi01i002.jpg GRAPHIC 167069
5 G87962BI01I003.JPG g87962bi01i003.jpg GRAPHIC 78563
  Complete submission text file 0001047469-16-012564.txt   876159
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37508 | Film No.: 161592901
SIC: 2834 Pharmaceutical Preparations